Literature DB >> 21830988

Deferoxamine for advanced hepatocellular carcinoma.

Takahiro Yamasaki, Shuji Terai, Isao Sakaida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21830988     DOI： 10.1056/NEJMc1105726

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  57 in total

Review 1.  Current Status of Hepatic Arterial Infusion Chemotherapy.

Authors:  Shuntaro Obi; Shinpei Sato; Toshihiro Kawai
Journal:  Liver Cancer       Date:  2015-08-12       Impact factor: 11.740

2.  Histopathology of type C liver disease for determining hepatocellular carcinoma risk factors.

Authors:  Hiroshi Matsumura; Kazushige Nirei; Hitomi Nakamura; Teruhisa Higuchi; Yasuo Arakawa; Masahiro Ogawa; Naohide Tanaka; Mitsuhiko Moriyama
Journal:  World J Gastroenterol       Date:  2013-08-14       Impact factor: 5.742

3.  Current chemotherapies for advanced hepatocellular carcinoma.

Authors:  Kazuhiro Nouso
Journal:  Clin J Gastroenterol       Date:  2013-02-06

Review 4.  An update on iron chelation therapy.

Authors:  Erika Poggiali; Elena Cassinerio; Laura Zanaboni; Maria Domenica Cappellini
Journal:  Blood Transfus       Date:  2012-06-27       Impact factor: 3.443

Review 5.  Iron and Cancer.

Authors:  Suzy V Torti; David H Manz; Bibbin T Paul; Nicole Blanchette-Farra; Frank M Torti
Journal:  Annu Rev Nutr       Date:  2018-08-21       Impact factor: 11.848

Review 6.  p53 tumor suppressor and iron homeostasis.

Authors:  Jin Zhang; Xinbin Chen
Journal:  FEBS J       Date:  2018-09-04       Impact factor: 5.542

7.  IRP2 regulates breast tumor growth.

Authors:  Wei Wang; Zhiyong Deng; Heather Hatcher; Lance D Miller; Xiumin Di; Lia Tesfay; Guangchao Sui; Ralph B D'Agostino; Frank M Torti; Suzy V Torti
Journal:  Cancer Res       Date:  2013-11-27       Impact factor: 12.701

Review 8.  Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver function.

Authors:  Taro Takami; Takahiro Yamasaki; Issei Saeki; Toshihiko Matsumoto; Yutaka Suehiro; Isao Sakaida
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

9.  Enzymatically Biodegradable Polyrotaxane-Deferoxamine Conjugates for Iron Chelation.

Authors:  Zhi Liu; Tien-Min Lin; Max Purro; May P Xiong
Journal:  ACS Appl Mater Interfaces       Date:  2016-09-26       Impact factor: 9.229

Review 10.  The role of iron homeostasis and iron-mediated ROS in cancer.

Authors:  Jia-Fu Ying; Ze-Bei Lu; Luo-Qin Fu; Yu Tong; Zhen Wang; Wei-Fen Li; Xiao-Zhou Mou
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.